Article Versions Notes

Tóth GD, Kazsoki A, Gyarmati B, Szilágyi A, Vasvári G, Katona G, Szente L, Zelkó R, Poppe L, Balogh-Weiser D, et al. Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies. Pharmaceutics. 2021; 13(7):972. https://doi.org/10.3390/pharmaceutics13070972

Tóth, Gergő Dániel, Adrienn Kazsoki, Benjámin Gyarmati, András Szilágyi, Gábor Vasvári, Gábor Katona, Lajos Szente, Romána Zelkó, László Poppe, Diána Balogh-Weiser, and et al. 2021. "Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies" Pharmaceutics 13, no. 7: 972. https://doi.org/10.3390/pharmaceutics13070972

Tóth, G. D., Kazsoki, A., Gyarmati, B., Szilágyi, A., Vasvári, G., Katona, G., Szente, L., Zelkó, R., Poppe, L., Balogh-Weiser, D., & Balogh, G. T. (2021). Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies. Pharmaceutics, 13(7), 972. https://doi.org/10.3390/pharmaceutics13070972